← All organizations

Noveome Biotherapeutics

For profitWebsite ↗

Also known as: Noveome Biotherapeutics, formerly Stemnion | Noveome Biotherapeutics, Inc

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Aug 19, 2024

Timeline

2000s

Jun 1, 2000
Noveome Biotherapeutics— Founded

Drugs by trial phase (4 distinct, 13 trials)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

cellulose

Indications

Studied for

Recent trials (19)

NCT06315738Lead sponsorPhase 1/Phase 2Aug 19, 2024
NCT05066698Lead sponsorPhase 2Oct 13, 2021
NCT04720378Study directorPhase 1May 30, 2021
NCT04720378Lead sponsorPhase 1May 30, 2021
NCT03901781Lead sponsorPhase 1Jun 1, 2019
NCT03687632Lead sponsorPhase 2Oct 31, 2018
NCT02978183Lead sponsorPhase 2Dec 1, 2016
NCT02761993Lead sponsorPhase 2Apr 1, 2016
NCT02369861Lead sponsorPhase 1Mar 1, 2015
NCT02389777Lead sponsorPhase 2Mar 1, 2015
NCT02369861Study directorPhase 1Mar 1, 2015
NCT02389777Study directorPhase 2Mar 1, 2015
NCT02071199Study directorPhase 1Mar 1, 2014
NCT02071199Lead sponsorPhase 1Mar 1, 2014
NCT01714973Lead sponsorPhase 1Oct 1, 2012

Details

Founded: Pittsburgh, PA, US Jun 1, 2000
Last known activity: Aug 19, 2024